Skip to content

Contact +44 (0) 20 7060 7474 email us

Search Results


The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Carvedilol: Pipeline™ Selector'

Title Publication Date Price Relevance
Carvedilol
Pipeline Developer
Ongoing £2485 100 %
Carvedilol: Core Country Coverage
Pipeline Selector
Ongoing £260 96 %
Carvedilol: Extended Country Coverage
Pipeline Selector
Ongoing £610 96 %
Hypertension - Treatments and Prescribing Practices
A Global Survey 2009
October 2009 £4165 50 %
Daiichi Sankyo
Pipeline, Products, Performance, Potential
October 2008 £595 35 %
Daiichi Sankyo: Pipeline, Products, Performance, Potential
June 2008 £595 35 %
GlaxoSmithKline Prospects to 2010
Pipeline, Products,Performance,Potential
November 2008 £595 23.8 %
Teva Pharmaceutical Industries Generics Company Intelligence Report
June 2008 £195 20.65 %
China Hypertension Drug Market Report
The Chinese Hospital Cancer Drug Utilization
February 2009 £5090 18.55 %
Dr Reddy's Laboratories Generics Company Intelligence Report
June 2008 £195 16.8 %
Dr Reddy's Laboratories Generics Company Intelligence Report
June 2008 £195 16.8 %
Generic Benchmarking: Brand Erosion at Patent Expiry
Healthcare
March 2009 £4000 16.45 %
Mylan Laboratories Generics Company Intelligence Report
June 2008 £195 15.75 %
Dr Reddy Generics Company Intelligence Report
Company Intelligence Report
March 2009 £195 14.35 %
Cardiovascular Generic Drugs
Prospects and Opportunities to 2012
December 2007 £995 13.3 %
Teva Generics Company Intelligence Report
Company Intelligence Report
March 2009 £195 10.15 %
Generic Competition, 2007–11
The impact of patent expiries on sales of major drugs
February 2007 £1375 7.7 %
World Generic Market Report 2009
January 2009 £595 5.95 %
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6
Compressed Solid Products
April 2007 £195 5.25 %